A protective role for kidney apolipoprotein E. Regulation of mesangial cell proliferation and matrix expansion (Q43752261)

26 November 2017

title

A protective role for kidney apolipoprotein E. Regulation of mesangial cell proliferation and matrix expansion (English)

1 reference

26 November 2017

1 reference

Chen G

1 reference

26 November 2017

Paka L

1 reference

26 November 2017

Kako Y

1 reference

26 November 2017

Singhal P

1 reference

26 November 2017

Duan W

1 reference

26 November 2017

Pillarisetti S

1 reference

26 November 2017

language of work or name

English

0 references

publication date

28 September 2001

1 reference

Journal of Biological Chemistry

26 November 2017

published in

1 reference

26 November 2017

volume

276

1 reference

26 November 2017

1 reference

26 November 2017

page(s)

49142-49147

1 reference

Mechanisms of progressive renal disease in glomerulonephritis

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104879200

Regulation of filtration rate by glomerular mesangial cells in health and diabetic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104879200

Pathogenesis of Diabetic Vascular Disease: Evidence for the Role of Reduced Heparan Sulfate Proteoglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104879200

Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104879200

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104879200

Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104879200

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104879200

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104879200

Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104879200

Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104879200

Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104879200

Apolipoprotein E inhibits platelet-derived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104879200

Perlecan mediates the antiproliferative effect of apolipoprotein E on smooth muscle cells. An underlying mechanism for the modulation of smooth muscle cell growth?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104879200

Apolipoprotein E synthesis in human kidney, adrenal gland, and liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104879200

Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104879200

Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104879200

Regulation of mesangial cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104879200

The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104879200

Recent insights into the structure and functions of heparan sulfate proteoglycans in the human glomerular basement membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104879200

Apolipoprotein E polymorphism and renal function in German type 1 and type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104879200

TGF-beta in diabetic kidney disease: role of novel signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104879200

Regulation of mesangial cell apoptosis and proliferation by intracellular Ca(2+) signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104879200

The heparin-binding proteins apolipoprotein E and lipoprotein lipase enhance cellular proteoglycan production

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104879200

Lipoprotein modulation of subendothelial heparan sulfate proteoglycans (perlecan) and atherogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104879200

Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104879200

Association of Apolipoprotein 2 Allele With Diabetic Nephropathy in Caucasian Subjects With IDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104879200

21 January 2018

Identifiers

DOI

10.1074/JBC.M104879200

1 reference

26 November 2017

1 reference